Here's why you should be paying attention to this new, upcoming Alzheimer disease treatment...
Fiona Elwood, PhD
Advertisement
Dr Elwood is the Disease Area Stronghold Lead for Neurodegeneration at Johnson & Johnson.
Articles by Fiona Elwood, PhD
Advertisement
Latest Updated Articles
Posdinemab: Addressing the Unmet Need in Alzheimer DiseasePublished: January 22nd 2025 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Exploring CBT Approaches for Chronic Insomnia in Adults: A Systematic Review and Network Meta-Analysis
2
FDA Accepts NDA for CTx-1301 for Treatment of ADHD
3
New Data on Lumateperone for Prevention of Relapse in Schizophrenia
4
Medical Morality vs Chatbot Morality
5
